Recent news on

Gilead Announces Presentation of Positive Phase III Data on ...  -  Apr 20, 2007
PharmaLive.com (press release),More than 85 percent of patients were taking medication (dornase alfa) to thin mucus secretions in the lungs and nearly 70 percent were taking oral

New England Journal of Medicine Publishes Data from Pivotal Study ...  -  Dec 14, 2006
PharmaLive.com (press release),...patients in the United States, except for Pulmozyme(R) (dornase alfa, recombinant), which is covered by the Genentech Endowment for Cystic Fibrosis.

New England Journal of Medicine Publishes Data From Pivotal Study ...  -  Dec 14, 2006
PipelineReview.com (press release),...and donates free product to eligible uninsured patients in the United States, except for Pulmozyme®(dornase alfa, recombinant), which is covered by the

Galapagos wins grant for cystic fibrosis programme  -  Nov 27, 2006
OutSourcing-Pharma.com,The first drug developed specifically for cystic fibrosis, Roche/Genentech's Pulmozyme (dornase alfa), was approved in the mid-1990s as a mucus thinning

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional